These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 29532227)
1. Predictors of recurrence and survival of pathological T1N0M0 invasive adenocarcinoma following lobectomy. Wang Y; Zheng D; Zheng J; Huang Q; Han B; Zhang J; Zhao H; Chen H J Cancer Res Clin Oncol; 2018 Jun; 144(6):1015-1023. PubMed ID: 29532227 [TBL] [Abstract][Full Text] [Related]
2. Cavity Formation is a Prognostic Indicator for Pathologic Stage I Invasive Lung Adenocarcinoma of ≥3 cm in Size. Chen C; Fu S; Ni Q; Yiyang W; Pan X; Jing J; Zhao H; Rui W Med Sci Monit; 2019 Nov; 25():9003-9011. PubMed ID: 31772147 [TBL] [Abstract][Full Text] [Related]
3. Prognostic and predictive value of the novel classification of lung adenocarcinoma in patients with stage IB. Luo J; Huang Q; Wang R; Han B; Zhang J; Zhao H; Fang W; Luo Q; Yang J; Yang Y; Zhu L; Chen T; Cheng X; Wang Y; Zheng J; Wu H; Xia W; Chen H J Cancer Res Clin Oncol; 2016 Sep; 142(9):2031-40. PubMed ID: 27379889 [TBL] [Abstract][Full Text] [Related]
4. Predicting the recurrence risk factors and clinical outcomes of peripheral pulmonary adenocarcinoma ≤3 cm with wedge resection. Wang Y; Wang R; Zheng D; Han B; Zhang J; Zhao H; Luo J; Zheng J; Chen T; Huang Q; Sun Y; Chen H J Cancer Res Clin Oncol; 2017 Jun; 143(6):1043-1051. PubMed ID: 28204972 [TBL] [Abstract][Full Text] [Related]
5. The indication of completion lobectomy for lung adenocarcinoma ≤3 cm after wedge resection during surgical operation. Wang Y; Wang R; Zheng D; Han B; Zhang J; Zhao H; Luo J; Zheng J; Chen T; Huang Q; Sun Y; Chen H J Cancer Res Clin Oncol; 2017 Oct; 143(10):2095-2104. PubMed ID: 28616702 [TBL] [Abstract][Full Text] [Related]
6. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study. Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M J Thorac Cardiovasc Surg; 2013 Aug; 146(2):358-64. PubMed ID: 23477694 [TBL] [Abstract][Full Text] [Related]
7. Does the histologic predominance of pathological stage IA lung adenocarcinoma influence the extent of resection? Ito H; Nakayama H; Murakami S; Yokose T; Katayama K; Miyata Y; Okada M Gen Thorac Cardiovasc Surg; 2017 Sep; 65(9):512-518. PubMed ID: 28593420 [TBL] [Abstract][Full Text] [Related]
8. [Association between the presence of solid or micropapillary components and survival outcome in stage ⅠA lung adenocarcinoma cases: a retrospective cohort study]. Jin KQ; Shen YR; Wu YM; Dai J; Liu XG; Li JQ; Chen LS; Jiang GN Zhonghua Wai Ke Za Zhi; 2022 Jun; 60(6):587-592. PubMed ID: 35658347 [No Abstract] [Full Text] [Related]
9. Adjuvant Chemotherapy Candidates in Stage I Lung Adenocarcinomas Following Complete Lobectomy. Qian J; Xu J; Wang S; Qian F; Yang W; Zhang B; Zhang Y; Nie W; Lou Y; Lu J; Zhang X; Zhang W; Chu T; Zhong H; Fang W; Zhao H; Han B Ann Surg Oncol; 2019 Aug; 26(8):2392-2400. PubMed ID: 31011907 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance and adjuvant chemotherapy survival benefits of a solid or micropapillary pattern in patients with resected stage IB lung adenocarcinoma. Qian F; Yang W; Wang R; Xu J; Wang S; Zhang Y; Jin B; Yu K; Han B J Thorac Cardiovasc Surg; 2018 Mar; 155(3):1227-1235.e2. PubMed ID: 29223834 [TBL] [Abstract][Full Text] [Related]
11. Risk stratification model for patients with stage I invasive lung adenocarcinoma based on clinical and pathological predictors. Wang Y; Zheng D; Luo J; Zhang J; Pompili C; Ujiie H; Matsuura N; Chen H; Yao F Transl Lung Cancer Res; 2021 May; 10(5):2205-2217. PubMed ID: 34164270 [TBL] [Abstract][Full Text] [Related]
12. A prognostic nomogram based on a new classification of combined micropapillary and solid components for stage IA invasive lung adenocarcinoma. Huang W; Zhang H; Zhang Z; Zhang B; Sun X; Huo Y; Feng Y; Tian P; Mo H; Wang C J Surg Oncol; 2022 Mar; 125(4):796-808. PubMed ID: 34862621 [TBL] [Abstract][Full Text] [Related]
13. Comparison of outcomes following lobectomy, segmentectomy, and wedge resection based on pathological subtyping in patients with pN0 invasive lung adenocarcinoma ≤1 cm. Song W; Hou Y; Zhang J; Zhou Q Cancer Med; 2022 Dec; 11(24):4784-4795. PubMed ID: 35570370 [TBL] [Abstract][Full Text] [Related]
14. Micropapillary and Solid Histologic Patterns in N1 and N2 Lymph Node Metastases Are Independent Factors of Poor Prognosis in Patients With Stages II to III Lung Adenocarcinoma. Li Y; Byun AJ; Choe JK; Lu S; Restle D; Eguchi T; Tan KS; Saini J; Huang J; Rocco G; Jones DR; Travis WD; Adusumilli PS J Thorac Oncol; 2023 May; 18(5):608-619. PubMed ID: 36681298 [TBL] [Abstract][Full Text] [Related]
15. Risk Factors of Recurrence in Patients With Clinical Stage IA Adenocarcinoma Presented as Ground-Glass Nodule. Su H; Dai C; Xie H; Ren Y; She Y; Kadeer X; Xie D; Zheng H; Jiang G; Chen C Clin Lung Cancer; 2018 Sep; 19(5):e609-e617. PubMed ID: 29803575 [TBL] [Abstract][Full Text] [Related]
16. Cryobiopsy as a reliable technique for the preoperative identification of micropapillary/solid components in early-stage lung adenocarcinoma. Suzuki M; Matsumoto Y; Imabayashi T; Teishikata T; Tsuchida T; Asamura H; Yatabe Y Lung Cancer; 2021 Dec; 162():147-153. PubMed ID: 34814012 [TBL] [Abstract][Full Text] [Related]
17. Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2cm or smaller. Nitadori J; Bograd AJ; Kadota K; Sima CS; Rizk NP; Morales EA; Rusch VW; Travis WD; Adusumilli PS J Natl Cancer Inst; 2013 Aug; 105(16):1212-20. PubMed ID: 23926067 [TBL] [Abstract][Full Text] [Related]
18. Prognostic Impact of the Findings on Thin-Section Computed Tomography in Patients with Subcentimeter Non-Small Cell Lung Cancer. Hattori A; Matsunaga T; Hayashi T; Takamochi K; Oh S; Suzuki K J Thorac Oncol; 2017 Jun; 12(6):954-962. PubMed ID: 28257958 [TBL] [Abstract][Full Text] [Related]
19. Solid predominant histologic subtype and early recurrence predict poor postrecurrence survival in patients with stage I lung adenocarcinoma. Luo J; Wang R; Han B; Zhang J; Zhao H; Fang W; Luo Q; Yang J; Yang Y; Zhu L; Chen T; Cheng X; Huang Q; Wang Y; Zheng J; Chen H Oncotarget; 2017 Jan; 8(4):7050-7058. PubMed ID: 27732964 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society lung adenocarcinoma classification on death and recurrence in completely resected stage I lung adenocarcinoma. Hung JJ; Jeng WJ; Chou TY; Hsu WH; Wu KJ; Huang BS; Wu YC Ann Surg; 2013 Dec; 258(6):1079-86. PubMed ID: 23532112 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]